Company Filing History:
Years Active: 2014
Title: Leanne Berry: Innovator in Cancer Treatment
Introduction
Leanne Berry is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents.
Latest Patents
Leanne Berry holds 1 patent for her work on "Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use." This patent focuses on the use of the antibody-drug conjugate trastuzumab-MCC-DM1 in combination with various chemotherapeutic agents. These combinations are designed to inhibit tumor cell growth and treat disorders such as cancer mediated by HER2 and KDR (VEGFR receptor 1). The patent also discloses methods for using these combinations for diagnosis, prevention, or treatment of related disorders in mammalian cells.
Career Highlights
Leanne Berry is associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her work has been instrumental in advancing cancer therapies and improving patient outcomes.
Collaborations
Throughout her career, Leanne has collaborated with notable colleagues, including Gail Lewis Phillips and Mark X Sliwkowski. These partnerships have contributed to her success in the field of cancer research and development.
Conclusion
Leanne Berry's contributions to cancer treatment through her innovative patent and collaborations highlight her role as a key inventor in the biotechnology industry. Her work continues to impact the lives of many patients facing cancer.